PubMed

CYP17 5'-UTR MspA1 polymorphism and the risk of premenopausal breast cancer in a German population-based case-control study.

Verla-Tebit E, Wang-Gohrke S, Chang-Claude J.

Breast Cancer Res. 2005;7(4):R455-64. Epub 2005 Apr 12.PMID: 15987450 [PubMed - indexed for MEDLINE]Related articlesFree article

The CYP17 MspA1 polymorphism and breast cancer risk: a meta-analysis.

Ye Z, Parry JM.

Mutagenesis. 2002 Mar;17(2):119-26.PMID: 11880540 [PubMed - indexed for MEDLINE]Related articlesFree article

Increased risk of prostate cancer and benign prostatic hyperplasia associated with a CYP17 gene polymorphism with a gene dosage effect.

Habuchi T, Liqing Z, Suzuki T, Sasaki R, Tsuchiya N, Tachiki H, Shimoda N, Satoh S, Sato K, Kakehi Y, Kamoto T, Ogawa O, Kato T.

Cancer Res. 2000 Oct 15;60(20):5710-3.PMID: 11059764 [PubMed - indexed for MEDLINE]Related articlesFree article

CYP17 genetic polymorphism, breast cancer, and breast cancer risk factors.

Ambrosone CB, Moysich KB, Furberg H, Freudenheim JL, Bowman ED, Ahmed S, Graham S, Vena JE, Shields PG.

Breast Cancer Res. 2003;5(2):R45-51. Epub 2003 Jan 29.PMID: 12631398 [PubMed - indexed for MEDLINE]Related articlesFree article

Genetic polymorphism of CYP17 and breast cancer risk in Korean women.

Shin MH, Lee KM, Yang JH, Nam SJ, Kim JW, Yoo KY, Park SK, Noh DY, Ahn SH, Kim B, Kang D.

Exp Mol Med. 2005 Feb 28;37(1):11-7.PMID: 15761247 [PubMed - indexed for MEDLINE]Related articlesFree article

The relationship between a polymorphism in CYP17 with plasma hormone levels and breast cancer.

Haiman CA, Hankinson SE, Spiegelman D, Colditz GA, Willett WC, Speizer FE, Kelsey KT, Hunter DJ.

Cancer Res. 1999 Mar 1;59(5):1015-20.PMID: 10070957 [PubMed - indexed for MEDLINE]Related articlesFree article

CYP17 gene polymorphism and its association with high-risk north Indian breast cancer patients.

Chakraborty A, Murthy NS, Chintamani C, Bhatnagar D, Mohil RS, Sharma PC, Saxena S.

J Hum Genet. 2007;52(2):159-65. Epub 2007 Jan 18.PMID: 17235448 [PubMed - indexed for MEDLINE]Related articles

CYP17 genotype modifies the association between lignan supply and premenopausal breast cancer risk in humans.

Piller R, Verla-Tebit E, Wang-Gohrke S, Linseisen J, Chang-Claude J.

J Nutr. 2006 Jun;136(6):1596-603.PMID: 16702327 [PubMed - indexed for MEDLINE]Related articlesFree article

A polymorphism in CYP17 and endometrial cancer risk.

Haiman CA, Hankinson SE, Colditz GA, Hunter DJ, De Vivo I.

Cancer Res. 2001 May 15;61(10):3955-60.PMID: 11358812 [PubMed - indexed for MEDLINE]Related articlesFree article

CYP17 MspA1 polymorphism and risk of biliary tract cancers and gallstones: a population-based study in Shanghai, China.

Hou L, Xu J, Gao YT, Rashid A, Zheng SL, Sakoda LC, Shen MC, Wang BS, Deng J, Han TQ, Zhang BH, Meyers DA, Fraumeni JF Jr, Hsing AW.

Int J Cancer. 2006 Jun 1;118(11):2847-53.PMID: 16381022 [PubMed - indexed for MEDLINE]Related articles

Steroid metabolism gene CYP17 polymorphism and the development of breast cancer.

Mitrunen K, Jourenkova N, Kataja V, Eskelinen M, Kosma VM, Benhamou S, Vainio H, Uusitupa M, Hirvonen A.

Cancer Epidemiol Biomarkers Prev. 2000 Dec;9(12):1343-8.PMID: 11142420 [PubMed - indexed for MEDLINE]Related articlesFree article

A polymorphism in the CYP17 gene relates to the risk of recurrent pregnancy loss.

Sata F, Yamada H, Yamada A, Kato EH, Kataoka S, Saijo Y, Kondo T, Tamaki J, Minakami H, Kishi R.

Mol Hum Reprod. 2003 Nov;9(11):725-8.PMID: 14561815 [PubMed - indexed for MEDLINE]Related articlesFree article

CYP17 promoter polymorphism and breast cancer in Australian women under age forty years.

Spurdle AB, Hopper JL, Dite GS, Chen X, Cui J, McCredie MR, Giles GG, Southey MC, Venter DJ, Easton DF, Chenevix-Trench G.

J Natl Cancer Inst. 2000 Oct 18;92(20):1674-81.PMID: 11036113 [PubMed - indexed for MEDLINE]Related articlesFree article

A polymorphism in the CYP17 gene increases the risk of breast cancer.

Feigelson HS, Coetzee GA, Kolonel LN, Ross RK, Henderson BE.

Cancer Res. 1997 Mar 15;57(6):1063-5.PMID: 9067272 [PubMed - indexed for MEDLINE]Related articlesFree article

CYP17 genetic polymorphism, breast cancer, and breast cancer risk factors: Australian Breast Cancer Family Study.

Chang JH, Gertig DM, Chen X, Dite GS, Jenkins MA, Milne RL, Southey MC, McCredie MR, Giles GG, Chenevix-Trench G, Hopper JL, Spurdle AB.

Breast Cancer Res. 2005;7(4):R513-21. Epub 2005 May 12.PMID: 15987458 [PubMed - indexed for MEDLINE]Related articlesFree article

Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: a multigenic study on cancer susceptibility.

Huang CS, Chern HD, Chang KJ, Cheng CW, Hsu SM, Shen CY.

Cancer Res. 1999 Oct 1;59(19):4870-5.PMID: 10519398 [PubMed - indexed for MEDLINE]Related articlesFree article

Polymorphisms of estrogen-metabolizing genes and breast cancer risk: a multigenic study.

Han DF, Zhou X, Hu MB, Xie W, Mao ZF, Chen DE, Liu F, Zheng F.

Chin Med J (Engl). 2005 Sep 20;118(18):1507-16.PMID: 16232327 [PubMed - indexed for MEDLINE]Related articlesFree article

CYP17, GSTP1, PON1 and GLO1 gene polymorphisms as risk factors for breast cancer: an Italian case-control study.

Antognelli C, Del Buono C, Ludovini V, Gori S, Talesa VN, Crinò L, Barberini F, Rulli A.

BMC Cancer. 2009 Apr 20;9:115.PMID: 19379515 [PubMed - indexed for MEDLINE]Related articlesFree article

Association of genetic polymorphisms of ER-alpha and the estradiol-synthesizing enzyme genes CYP17 and CYP19 with breast cancer risk in Chinese women.

Zhang L, Gu L, Qian B, Hao X, Zhang W, Wei Q, Chen K.

Breast Cancer Res Treat. 2009 Mar;114(2):327-38. Epub 2008 Jul 16.PMID: 18629629 [PubMed - indexed for MEDLINE]Related articles

The relationship between a polymorphism in CYP17 with plasma hormone levels and prostate cancer.

Haiman CA, Stampfer MJ, Giovannucci E, Ma J, Decalo NE, Kantoff PW, Hunter DJ.

Cancer Epidemiol Biomarkers Prev. 2001 Jul;10(7):743-8.PMID: 11440959 [PubMed - indexed for MEDLINE]Related articlesFree article